- Rapidly Growing Interval Colon Cancer
-
Kim JH, Park MI
- KMID: 2373231
- Korean J Gastroenterol.
- 2015 May;65(5):326-329.
- doi: 10.4166/kjg.2015.65.5.326
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pancreatic Endocrine Tumors: A Report on a Patient Treated with Sorafenib
-
Jeong HK, Roh SY, Hong SH, Won HS, Jeon EK, Shin OR, Lee SL, Ko YH
- KMID: 1094270
- J Korean Med Sci.
- 2011 Jul;26(7):954-958.
- doi: 10.3346/jkms.2011.26.7.954
A 31-yr-old man with abdominal pain was diagnosed with a pancreatic endocrine tumor and multiple hepatic metastases. Despite optimal treatment with interferon alpha, a somatostatin analog, local therapy with high-intensity... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways
-
Kim H, Lim HY
- KMID: 1786011
- J Korean Med Sci.
- 2011 Dec;26(12):1563-1568.
- doi: 10.3346/jkms.2011.26.12.1563
Epidermal growth factor receptor (EGFR)-targeted therapies have been effective in some cancers, but not in hepatocellular carcinoma (HCC). The aim of this study was to investigate the drug potential to... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
-
Cha J, Seong J, Lee IJ, Kim JW, Han KH
- KMID: 1793165
- Yonsei Med J.
- 2013 Sep;54(5):1178-1185.
- doi: 10.3349/ymj.2013.54.5.1178
PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July... -
- CITED
-
- Close
- SHARE
-
- Close
- Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model
-
Park HS, Han JK, Lee JM, Kim YI, Woo S, Yoon JH, Choi JY, Choi BI
- KMID: 2160770
- Korean J Radiol.
- 2015 Oct;16(5):1029-1037.
- doi: 10.3348/kjr.2015.16.5.1029
OBJECTIVE: To evaluate the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) using macromolecular contrast agent (P792) for assessment of vascular disrupting drug effect in rabbit VX2 liver tumor models. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
